Abiraterone acetate is a prodrug of abiraterone, which irreversibly inhibits CYP17A1, an enzyme critical to androgen biosynthesis in the testes, adrenal glands, and within the tumor microenvironment [59]. Here, CYP17A1 is linked to neoplasm.